Literature DB >> 27668532

Anti-proliferation effects, efficacy of cyasterone in vitro and in vivo and its mechanism.

XinGang Lu1, HongFu Qiu2, Liu Yang3, JieYing Zhang4, ShuJie Ma5, Lan Zhen6.   

Abstract

Cyasterone was demonstrated potential inhibition effect in mouse skin carcinoma cells in published report. However, the molecular mechanisms of the cyasterone on cells remain unknown. Herein, we investigated the effects of cyasterone-induced apoptosis in A549 and MGC823 cells in vitro. MTT assay showed that cyasterone caused a significantly decreasing of the proliferation of A549 and MGC823 cells in a time-and dose-dependent manner with IC50 values of 38.50±3.73μg/mL on A549 cells and 32.96±1.24μg/mL on MGC823 cells at 48h, respectively. Hoechst staining and TUNEL staining results indicated the quintessential apoptosis features in immunofluorescence image. Apoptosis and cell cycle were determined by flow cytometry. Cyasterone treatment triggered inhibition of epidermal growth factor receptor- phosphatidylinositol 3 kinase/protein kinase B (EGFR-AKT) signaling pathways and activation of P38 pathways. Furthermore, cyasterone inhibited MGC823 cells xenografted tumor growth in vivo with few changes in body weights. In conclusion, our findings provide the evidence that cyasterone inhibits growth of A549 and MGC823 cells, via regulating EGFR signaling pathway. Our results indicated that cyasterone, a natural EGFR inhibitor, maybe a promising anti-cancer agent.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell cycle arrest; Cyasterone; EGFR signaling pathway

Mesh:

Substances:

Year:  2016        PMID: 27668532     DOI: 10.1016/j.biopha.2016.09.041

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  1 in total

1.  The Anti-Inflammatory Activity of Toonaciliatin K against Adjuvant Arthritis.

Authors:  HaiXing Gou; Jie Ye; YiRu Wang; XiaoLi Xu; QiXing Shen; JingWei Xue; Jie Zhao; XinGang Lu
Journal:  Biomed Res Int       Date:  2017-10-17       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.